Search Result
List
3Cases
2018-02-05 - 2022-12-31
Phase II
Completed
A Phase II, Randomized, Multi-Center, Double-Blind, Comparative Global Study to Determine the Efficacy and Safety of Durvalumab in Combination With Olaparib for First-Line Treatment in Cisplatin-Ineligible Patients With Unresectable Stage IV Urothelial Cancer
-
Condition/Disease
urothelial cancer
-
Test Drug
Durvalumab(MEDI4736) Olaparib
Participate Sites
10Sites
Terminated8Sites
Study ended1Sites
馮思中
Linkou Chang Gung Medical Foundation
Division of Hematology & Oncology
吳文正
Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital
Division of Urology
2018-01-22 - 2019-12-31
Phase III
-
Condition/Disease
Acute Ischemic Stroke or Transient ischaemic attack
-
Test Drug
BRILINTA
Participate Sites
16Sites
Recruiting15Sites
Study ended1Sites
李宗海
Linkou Chang Gung Medical Foundation
Division of Neurology
林秀芬
Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital
Division of Neurology
2015-12-01 - 2021-12-31
Phase III
-
Condition/Disease
Alzheimer′s disease
-
Test Drug
Aducanumab
Participate Sites
8Sites
Terminated7Sites
劉景寬
Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital
Division of Neurology
